Date: 29-SEPTEMBER-2021 Last Updated: 11-AUGUST-2026
Short Answer
No formal risk assessment has been conducted specifically for the use of SOLVFil™ in GMP laboratories.
However, significant consideration was given to product design, manufacturing, laboratory performance, and data integrity during the development of SOLVFil™ filtration devices.
As with any laboratory consumable used in regulated environments, individual laboratories should perform their own internal risk assessments and validation activities based on their quality systems, SOPs, and regulatory requirements.
Product Development and Data Integrity Considerations
SOLVFil™ devices were developed to provide a practical alternative to traditional vacuum filtration assemblies and glass filter funnels used during mobile phase preparation.
During product development, emphasis was placed on:
- Filtration efficiency
- Ease of use
- Laboratory productivity
- Reduction of handling steps
- Mobile phase preparation consistency
Internal laboratory use has not revealed evidence of adverse effects on chromatographic data quality when the devices are used according to recommended procedures.
Because the filtration mechanism is fundamentally based on membrane filtration technology, the same general considerations that apply to conventional membrane filtration methods also apply to SOLVFil™ devices.
Benefits Compared to Traditional Filtration Methods
Many laboratories find SOLVFil™ easier and faster to use than traditional glass vacuum filtration systems.
Advantages may include:
- Simplified mobile phase preparation
- Reduced equipment handling
- Fewer transfer steps
- Faster workflow execution
- Integrated filtration and degassing
Reducing preparation time can help improve laboratory efficiency while maintaining consistent solvent preparation practices.
Filtration and Degassing in a Single Step
In addition to removing undissolved particulate matter from mobile phases, SOLVFil™ devices can assist with solvent degassing when used under vacuum.
This offers several potential benefits:
- Reduced dissolved gases in the mobile phase
- Improved detector stability
- Reduced bubble formation
- Improved chromatography system performance
Because filtration occurs directly into the mobile phase reservoir bottle, solvent exposure to the atmosphere is minimized after preparation. Promptly capping the reservoir after filtration can further help reduce reabsorption of atmospheric gases such as oxygen.
Best Practices for Laboratory Use
Assign Each Device to a Specific Mobile Phase
For optimum laboratory practice, it is recommended that each SOLVFil™ device be dedicated to a specific:
- Mobile phase
- Buffer system
- Analytical method
Labeling devices with a laboratory marker can help prevent accidental interchange and reduce the potential for cross-contamination.
Extend Device Service Life
When used repeatedly with the same solvent or buffer system, SOLVFil™ devices can often provide extended service life.
Reuse should be limited to the same liquid system whenever possible.
Replace When Performance Declines
A device should be replaced when:
- Filtration performance decreases significantly
- Flow becomes excessively restricted
- The membrane becomes damaged
- Physical integrity is compromised
Following these practices can help maintain filtration consistency and support reliable chromatography results.
GMP Considerations
Laboratories operating under GMP requirements should evaluate SOLVFil™ devices within their own quality framework.
Considerations may include:
- Intended use
- Risk assessment procedures
- Validation requirements
- Change control processes
- Data integrity policies
- SOP requirements
Suitability for GMP applications should be determined by each organization's quality and compliance teams.
Key Takeaways
- No formal GMP risk assessment has been performed for SOLVFil™ devices.
- Product development included consideration of data integrity and laboratory performance.
- SOLVFil™ combines filtration and degassing in a single workflow.
- Direct filtration into mobile phase reservoir bottles may help reduce atmospheric exposure.
- Dedicated use for specific mobile phases or methods is recommended.
- GMP laboratories should perform their own internal qualification and risk assessment activities.